Systemic immune mediators reflect tumour-infiltrating lymphocyte intensity and predict therapeutic response in triple-negative breast cancer.
Lopes AD, Galdino NAL, Figueiredo AB, Brianese RC, Morais KLP, De Brot M, Osório CABT, Teixeira-Carvalho A, Calsavara VF, Evangelista GFB, Alves NS, Makdissi FB, Sanches SM, Cordeiro de Lima VC, Carraro DM, Gollob KJ.
Lopes AD, et al.
Immunology. 2023 Jun;169(2):229-241. doi: 10.1111/imm.13627. Epub 2023 Feb 20.
Immunology. 2023.
PMID: 36703241